71 related articles for article (PubMed ID: 20547311)
1. Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial.
Pinyol R; Montal R; Bassaganyas L; Sia D; Takayama T; Chau GY; Mazzaferro V; Roayaie S; Lee HC; Kokudo N; Zhang Z; Torrecilla S; Moeini A; Rodriguez-Carunchio L; Gane E; Verslype C; Croitoru AE; Cillo U; de la Mata M; Lupo L; Strasser S; Park JW; Camps J; Solé M; Thung SN; Villanueva A; Pena C; Meinhardt G; Bruix J; Llovet JM
Gut; 2019 Jun; 68(6):1065-1075. PubMed ID: 30108162
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma.
Llovet JM; Pinyol R; Yarchoan M; Singal AG; Marron TU; Schwartz M; Pikarsky E; Kudo M; Finn RS
Nat Rev Clin Oncol; 2024 Apr; 21(4):294-311. PubMed ID: 38424197
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant therapies in resectable hepatocellular carcinoma: Exploring strategies to improve prognosis.
Ma YN; Jiang X; Song P; Tang W
Biosci Trends; 2024 Mar; 18(1):21-41. PubMed ID: 38382930
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Analysis of Single Large Hepatocellular Carcinoma Following Radical Resection: A Single-Center Study.
Huang J; Li L; Liu FC; Tan BB; Yang Y; Jiang BG; Pan ZY
J Hepatocell Carcinoma; 2023; 10():573-586. PubMed ID: 37056420
[TBL] [Abstract][Full Text] [Related]
5. Effects of Achieving SVR on Clinical Characteristics and Surgical Outcomes in Patients Who Developed Early-Stage HCV-Related Hepatocellular Carcinoma and Received Curative Resection: Preoperative versus Postoperative SVR.
Hsu PY; Liang PC; Huang CI; Hsieh MH; Tsai YS; Lin TC; Yeh ML; Huang CF; Wang CW; Jang TY; Lin YH; Lin ZY; Chuang WL; Dai CY
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366510
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant Therapy for Hepatocellular Carcinoma.
Yin Z; Chen D; Liang S; Li X
J Hepatocell Carcinoma; 2022; 9():929-946. PubMed ID: 36068876
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Central Memory T Cells Combined With Adjuvant Therapy to Prevent Recurrence of Hepatocellular Carcinoma With Microvascular Invasion: A Pilot Study.
Cai J; Zhao J; Liu D; Xie H; Qi H; Ma J; Sun Z; Zhao H
Front Oncol; 2021; 11():781029. PubMed ID: 34926296
[TBL] [Abstract][Full Text] [Related]
8. A multidimensional nomogram combining imaging features and clinical factors to predict the invasiveness and metastasis of combined hepatocellular cholangiocarcinoma.
Wang Y; Zhou CW; Zhu GQ; Li N; Qian XL; Chong HH; Yang C; Zeng MS
Ann Transl Med; 2021 Oct; 9(20):1518. PubMed ID: 34790724
[TBL] [Abstract][Full Text] [Related]
9. The Epigenetic Regulation of HCC Metastasis.
Han TS; Ban HS; Hur K; Cho HS
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544763
[TBL] [Abstract][Full Text] [Related]
10. Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics.
Shen J; He L; Li C; Wen T; Chen W; Lu C; Yan L; Li B; Yang J
Oncotarget; 2016 Dec; 7(49):80783-80793. PubMed ID: 27811374
[TBL] [Abstract][Full Text] [Related]
11. Hepatic artery injection of ¹³¹I-labelled metuximab combined with chemoembolization for intermediate hepatocellular carcinoma: a prospective nonrandomized study.
Wu L; Yang YF; Ge NJ; Shen SQ; Liang J; Wang Y; Zhou WP; Shen F; Wu MC
Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1306-15. PubMed ID: 22588627
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas.
Chen J; Li G; Meng H; Fan Y; Song Y; Wang S; Zhu F; Guo C; Zhang L; Shi Y
Cancer Immunol Immunother; 2012 Jan; 61(1):101-8. PubMed ID: 21853301
[TBL] [Abstract][Full Text] [Related]
13. [Multimodality treatment for hepatocellular carcinoma].
Malek NP; Vogel A; Manns MP
Internist (Berl); 2010 Nov; 51(11):1374-81. PubMed ID: 20938626
[TBL] [Abstract][Full Text] [Related]
14. Treatment of early hepatocellular carcinoma: How to predict and prevent recurrence.
Andreana L; Burroughs AK
Dig Liver Dis; 2010 Jul; 42 Suppl 3():S249-57. PubMed ID: 20547311
[TBL] [Abstract][Full Text] [Related]
15. Surgery and transplantation for hepatocellular cancer.
Wall WJ; Marotta PJ
Liver Transpl; 2000 Nov; 6(6 Suppl 2):S16-22. PubMed ID: 11084080
[TBL] [Abstract][Full Text] [Related]
16. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
17. [New surgical approaches in the treatment of hepatocellular carcinoma].
Hoffmann K; Schmidt J
Z Gastroenterol; 2009 Jan; 47(1):61-7. PubMed ID: 19156593
[TBL] [Abstract][Full Text] [Related]
18. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
Zhang GQ; Ge L; Ding W; Li HJ
Ai Zheng; 2008 Dec; 27(12):1297-301. PubMed ID: 19079997
[TBL] [Abstract][Full Text] [Related]
19. Current approaches to the treatment of early hepatocellular carcinoma.
Ye SL; Takayama T; Geschwind J; Marrero JA; Bronowicki JP
Oncologist; 2010; 15 Suppl 4():34-41. PubMed ID: 21115579
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
